Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Effects of Pacifier-Activated Lullaby on Oral Feeding Among Preterm Infants (Music therapy)

9 de septiembre de 2026 actualizado por: Sreekanth Viswanathan, Nemours Children's Clinic

Preterm infants often have difficulty learning how to feed by mouth because the coordination of sucking, swallowing, and breathing develops later in pregnancy. Delays in achieving full oral feeding can prolong hospitalization and increase the need for tube feeding.

This study evaluated whether a Pacifier-Activated Lullaby (PAL) system could improve oral feeding performance in preterm infants. The PAL device plays a recorded maternal or caregiver voice when an infant generates an adequate non-nutritive suck on a pacifier, providing positive reinforcement during feeding development.

In this randomized controlled trial conducted at Nemours Children's Hospital in Orlando, Florida, preterm infants who were transitioning from tube feeding to oral feeding were assigned either to receive PAL therapy in addition to standard feeding care or to receive standard feeding care alone. Researchers compared measures of oral feeding performance, feeding efficiency, growth, and progression toward independent oral feeding between the two groups.

The goal of the study was to determine whether reinforcing non-nutritive sucking with auditory feedback could enhance feeding development and improve clinical outcomes in preterm infants. The information gained from this study may help clinicians better understand the role of music-assisted feeding interventions in neonatal care and identify which infants are most likely to benefit from this approach.

Descripción general del estudio

Estado

Reclutamiento

Descripción detallada

Premature infants frequently experience feeding difficulties because the coordination of sucking, swallowing, and breathing develops during the later stages of gestation. Many infants born very preterm require prolonged tube feeding before they can safely and effectively feed by mouth. Delays in the transition from tube feeding to full oral feeding may contribute to prolonged hospitalization, increased healthcare utilization, and challenges in growth and development.

Non-nutritive sucking (NNS), such as sucking on a pacifier without receiving nutrition, is considered an important developmental precursor to oral feeding. Previous studies have suggested that NNS may improve feeding readiness, support maturation of oral motor skills, and facilitate the transition to oral feeding. Researchers have also explored whether positive reinforcement techniques can further enhance these feeding behaviors.

The Pacifier-Activated Lullaby (PAL) system is an FDA-cleared device designed to reinforce non-nutritive sucking through auditory feedback. The system consists of a pressure-sensitive pacifier connected to a music player. When an infant generates a suck that meets a predefined threshold, the device plays a recorded voice, typically the infant's mother singing lullabies. The intervention is based on principles of operant conditioning, with the auditory stimulus serving as a reward for effective sucking behavior.

This study was designed to evaluate whether PAL therapy improves oral feeding performance in preterm infants compared with standard neonatal feeding care alone. The trial was conducted in the Level IV Neonatal Intensive Care Unit (NICU) at Nemours Children's Hospital in Orlando, Florida.

Eligible participants were preterm infants born at less than 32 weeks gestational age who had reached approximately 34 to 36 weeks postmenstrual age and were transitioning from tube feeding to oral feeding. Infants were required to be receiving a substantial portion of their nutrition enterally while still developing oral feeding skills. Infants requiring significant respiratory support or considered unsafe for oral feeding were excluded.

Participants were randomly assigned to either the intervention group or the control group. Infants in the intervention group received PAL therapy in addition to standard feeding care. During PAL sessions, a recording of the mother's voice or a caregiver's voice was played whenever the infant generated an adequate non-nutritive suck on the PAL pacifier. Infants in the control group received standard feeding care, including routine opportunities for non-nutritive sucking and developmental care practices used in the NICU.

Researchers evaluated multiple measures of feeding performance, including oral feeding proficiency, feeding efficiency, milk transfer, feeding duration, growth, progression toward full oral feeding, and related clinical outcomes. Safety was monitored throughout the study, and PAL sessions were discontinued if infants exhibited signs of physiologic instability or feeding intolerance.

The purpose of this study was to determine whether reinforcing non-nutritive sucking with an auditory reward could accelerate the development of feeding skills and improve clinical outcomes in preterm infants. The findings may help clinicians better understand the role of music-assisted and behavioral reinforcement interventions in neonatal feeding therapy and identify patient populations most likely to benefit from these approaches.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

46

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Florida
      • Orlando, Florida, Estados Unidos, 32827
        • Reclutamiento
        • Nemours Children's Hospital, Florida
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Caroline Chua, MD
        • Sub-Investigador:
          • Sreekanth Viswanathan, MD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria:

  • Preterm infants born at less than 32 weeks gestational age
  • Postmenstrual age between 34 0/7 and 35 6/7 weeks at enrollment
  • Receiving at least half of nutritional intake enterally and less than half orally
  • Written informed consent obtained from parent(s) or legal guardian(s)

Exclusion Criteria:

  • Mechanical ventilation at enrollment
  • Continuous positive airway pressure (CPAP) support
  • High-flow nasal cannula support >2 L/min
  • Determined by the treating medical team to be unsafe for oral feeding
  • Determined by feeding or speech specialists to be unsafe for oral feeding
  • Clinical instability preventing participation in study procedures

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Triple

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Pacifier-Activated Lullaby (PAL) Plus Standard Feeding Care
Preterm infants randomized to this arm received Pacifier-Activated Lullaby (PAL) therapy in addition to standard neonatal intensive care unit (NICU) feeding practices. The PAL device used a pressure-sensitive pacifier that activated playback of a recorded maternal or caregiver voice when the infant generated a predetermined non-nutritive sucking threshold. PAL sessions were administered by trained study personnel while infants continued to receive routine developmental care, non-nutritive sucking opportunities, and oral feeding advancement according to NICU protocols.

The Pacifier-Activated Lullaby (PAL) intervention is a device-based feeding therapy designed to reinforce non-nutritive sucking in preterm infants through contingent auditory feedback. The PAL system consists of a pressure-sensitive pacifier connected to a digital music player. When the infant generates a suck that meets a predetermined pressure threshold, the device automatically plays a prerecorded maternal or caregiver voice, typically lullabies or children's songs, providing positive reinforcement for effective sucking behavior.

Infants assigned to the intervention arm received PAL therapy in addition to standard neonatal intensive care unit (NICU) feeding care. Maternal voice recordings were obtained before initiation of therapy and uploaded to the PAL device. During intervention sessions, the infant was offered the PAL pacifier approximately 30-45 minutes before scheduled feedings. Auditory stimulation was activated only when the infant achieved the predefined sucking threshold.

Otros nombres:
  • Auditory Reinforcement of Non-Nutritive Sucking Using a Pacifier-Activated Lullaby Device
Sin intervención: Standard Feeding Care Alone
Preterm infants randomized to this arm received standard NICU feeding care without use of the Pacifier-Activated Lullaby device. Standard care included routine developmental care, opportunities for non-nutritive sucking using a conventional pacifier, nursing care, parental involvement, and advancement of oral feeding according to established NICU feeding practices and clinical judgment. Participants underwent the same outcome assessments as the intervention group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Overall Transfer (OT):
Periodo de tiempo: Baseline (Day 0) through completion of the intervention period (Day 14)
Assessment of overall milk transfer before and after the intervention. Overall Transfer (OT): volume consumed divided by the prescribed volume of each feed expressed as a percentage
Baseline (Day 0) through completion of the intervention period (Day 14)
Proficiency (PRO)
Periodo de tiempo: Baseline (Day 0) through completion of the intervention period (Day 14)
Milk volume consumed during the first 5 minutes divided by the prescribed volume of each feed, expressed as a percentage
Baseline (Day 0) through completion of the intervention period (Day 14)
Endurance (rate of transfer)
Periodo de tiempo: Baseline (Day 0) through completion of the intervention period (Day 14)
Endurance (rate of milk transfer) expressed as ml/min
Baseline (Day 0) through completion of the intervention period (Day 14)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Days to Full Oral Feeding
Periodo de tiempo: From randomization until achievement of full oral feeding or hospital discharge, whichever occurred first, for up to 15 weeks from randomization
Number of days required for participants to achieve full oral feeding without the need for supplemental gavage (tube) feeding.
From randomization until achievement of full oral feeding or hospital discharge, whichever occurred first, for up to 15 weeks from randomization
Number of Gavage Feeding Days
Periodo de tiempo: From randomization until achievement of full oral feeding or hospital discharge, whichever occurred first for up to 15 weeks from randomization
Number of days participants required gavage (tube) feeding support during the study period.
From randomization until achievement of full oral feeding or hospital discharge, whichever occurred first for up to 15 weeks from randomization
Daily Weight Gain
Periodo de tiempo: Baseline (Day 0) through completion of the intervention period (Day 14)
Change in body weight during the study period, including daily weight measurements, to assess the effect of PAL therapy on growth.
Baseline (Day 0) through completion of the intervention period (Day 14)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Caroline Chua, MD, Nemours Children's Hospital

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

16 de noviembre de 2020

Finalización primaria (Estimado)

31 de diciembre de 2026

Finalización del estudio (Estimado)

31 de marzo de 2027

Fechas de registro del estudio

Enviado por primera vez

31 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de septiembre de 2026

Publicado por primera vez (Actual)

15 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

15 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

De-identified individual participant data underlying the results reported in publications arising from this study may be shared with qualified researchers upon reasonable request. Requests will be reviewed by the study investigators and institution and may require a data use agreement to protect participant confidentiality. No directly identifiable participant information will be shared.

Marco de tiempo para compartir IPD

Available upon publication of the primary manuscript and for up to 5 years thereafter

Criterios de acceso compartido de IPD

De-identified individual participant data (IPD) underlying the results reported in publications arising from this study may be made available to qualified researchers upon reasonable request. Requests must include a scientifically sound research proposal and will be reviewed by the study investigators and Nemours Children's Health. Access may require approval by the appropriate institutional review board (IRB) and execution of a data use agreement. Only de-identified data and supporting study documentation necessary to conduct the approved analyses will be provided. Data will be shared through a secure electronic transfer method that complies with institutional privacy and security requirements.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

Sí

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir